New Alzheimer’s blood test p-tau217 offers hope but has limits

New Alzheimer’s blood test p-tau217 offers hope but has limits

A blood test measuring the p-tau217 protein is emerging as a potential game-changer for Alzheimer’s diagnosis, offering a less invasive alternative to traditional methods like spinal fluid tests or brain scans. A recent study published in JAMA and findings presented at the Alzheimer’s Association International Conference 2026 support its accuracy in detecting Alzheimer’s-related changes. However, experts emphasize that the test cannot replace cognitive assessments or imaging, which remain essential for a definitive diagnosis. The test is still being evaluated for broader clinical use.